These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35672825)

  • 1. Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment.
    Meyer M; Westenberg JN; Strasser J; Dürsteler KM; Lang UE; Krausz M; Vogel M
    Harm Reduct J; 2022 Jun; 19(1):63. PubMed ID: 35672825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study.
    Westenberg JN; Meyer M; Strasser J; Krausz M; Dürsteler KM; Falcato L; Vogel M
    Addict Sci Clin Pract; 2023 Mar; 18(1):15. PubMed ID: 36906604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.
    Vogel M; Meyer M; Westenberg JN; Kormann A; Simon O; Salim Hassan Fadlelseed R; Kurmann M; Bröer R; Devaud N; Sanwald U; Baumgartner S; Binder H; Strasser J; Krausz RM; Beck T; Dürsteler KM; Falcato L
    Harm Reduct J; 2023 Jan; 20(1):2. PubMed ID: 36611162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series.
    Vogel M; Köck P; Strasser J; Kalbermatten C; Binder H; Dürsteler KM; Walter M; Falcato L; Krausz M; Kormann A
    Eur Addict Res; 2022; 28(1):80-86. PubMed ID: 34311466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients.
    Klous MG; Van den Brink W; Van Ree JM; Beijnen JH
    Drug Alcohol Depend; 2005 Dec; 80(3):283-95. PubMed ID: 15916865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.
    Oviedo-Joekes E; Guh D; Brissette S; Marchand K; MacDonald S; Lock K; Harrison S; Janmohamed A; Anis AH; Krausz M; Marsh DC; Schechter MT
    JAMA Psychiatry; 2016 May; 73(5):447-55. PubMed ID: 27049826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. «One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment.
    Meyer M; Eichenberger R; Strasser J; Dürsteler KM; Vogel M
    Harm Reduct J; 2021 Dec; 18(1):134. PubMed ID: 34922561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
    F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
    Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacetylmorphine versus methadone for the treatment of opioid addiction.
    Oviedo-Joekes E; Brissette S; Marsh DC; Lauzon P; Guh D; Anis A; Schechter MT
    N Engl J Med; 2009 Aug; 361(8):777-86. PubMed ID: 19692689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.
    Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K
    Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics.
    Rentsch KM; Kullak-Ublick GA; Reichel C; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2001 Sep; 70(3):237-46. PubMed ID: 11557911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.
    Oviedo-Joekes E; Brissette S; MacDonald S; Guh D; Marchand K; Jutha S; Harrison S; Janmohamed A; Zhang DZ; Anis AH; Krausz M; Marsh DC; Schechter MT
    Drug Alcohol Depend; 2017 Jul; 176():55-62. PubMed ID: 28521199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
    Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
    Palis H; MacDonald S; Jun J; Oviedo-Joekes E
    Harm Reduct J; 2021 May; 18(1):57. PubMed ID: 34016137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating injectable opioid agonist treatment into a drug treatment court program: A case study.
    Jun JH; Fairbairn N
    Subst Abus; 2018; 39(4):493-496. PubMed ID: 29949453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA).
    Allen ST; Schneider KE; Rouhani S; White RH; Morris M; Owczarzak J; Sherman SG
    Ann Med; 2023 Dec; 55(1):2196435. PubMed ID: 37078710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
    Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.
    Oviedo-Joekes E; Sordo L; Guh D; Marsh DC; Lock K; Brissette S; Anis AH; Schechter MT
    Addict Behav; 2015 Feb; 41():81-6. PubMed ID: 25452049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.
    Oviedo-Joekes E; Nosyk B; Marsh DC; Guh D; Brissette S; Gartry C; Krausz M; Anis A; Schechter MT
    Clin Trials; 2009 Jun; 6(3):261-71. PubMed ID: 19528135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.